Type 2 diabetes risk

TCF7L2 affects insulin secretion and is the strongest common genetic signal for type 2 diabetes. It shifts risk, but lifestyle and weight remain the biggest levers.

What the TCF7L2 variant does

TCF7L2 is a transcription factor in the Wnt signalling pathway, and in the pancreas it helps set how well beta cells release insulin. The risk version of this variant is associated with a weaker incretin effect, meaning the insulin response to a meal, sensed through gut hormones, is blunted.

That mechanism matters for interpretation: this is a variant about insulin secretion rather than insulin resistance, which is the more common route into type 2 diabetes through excess weight.

How strong the evidence is

This is the largest common-variant effect on type 2 diabetes known, and among the most heavily replicated findings in human genetics. The catalogued association draws on a multi-ancestry study of more than 2.5 million people with a p-value below 1e-1300, and the site's evidence file links 54 separate publications for it.

A pooled meta-analysis of 17,202 cases and 29,195 controls put the effect at an odds ratio of 1.46 per copy of the risk allele, which is roughly a 30% to 50% increase per copy. That is unusually large for a common variant and still small next to the effect of body weight, age and physical activity.

How common it is, and where it is not

In 1000 Genomes reference data, about 9% of European-ancestry individuals carry two risk copies and 41% carry one, with similar figures in African and South Asian samples. In East Asian samples the risk allele is rare, with only about 5% carrying even one copy.

That is a useful example of why a single variant cannot explain population differences in diabetes: type 2 diabetes is common in East Asia at lower body weights, and the largest European risk variant is nearly absent there.

What matters more than this variant

Type 2 diabetes is among the most modifiable common conditions. In the Diabetes Prevention Program, an intensive lifestyle programme aiming for 7% weight loss and 150 minutes of activity a week reduced progression from prediabetes to diabetes by 58% over about three years, and metformin by 31%.

Neither arm of that trial was selected by genotype, and the effect sizes are far larger than the shift this variant describes. A risk genotype is a reason to know your fasting glucose or HbA1c, not a reason to expect diabetes.

What this variant does not tell you

Monogenic diabetes, including the MODY forms caused by single variants in genes such as HNF1A, HNF4A and GCK, is not read here and changes treatment when present. Diabetes diagnosed young, in a lean person, across several generations is the pattern that raises that question with a clinician.

It also cannot tell you whether you have diabetes now. That is a blood test, and it is the only thing that answers the question.

What each rs7903146 genotype means

rs7903146 has three possible genotypes: CC, CT and TT.

Average diabetes risk (rs7903146 CC). You don't carry the TCF7L2 variant most strongly tied to type 2 diabetes, so from what this gene shows your risk sits at the baseline. Weight, diet, activity and family history still shape your overall risk much more.

Slightly higher diabetes risk (rs7903146 CT). You carry one copy of the TCF7L2 variant, the strongest common genetic signal for type 2 diabetes. It affects how well your body releases insulin and modestly raises your risk. The good news is that diet, activity and weight remain the biggest levers, so the tendency is very manageable.

Higher diabetes risk (rs7903146 TT). You have two copies of the TCF7L2 variant linked to type 2 diabetes, which more noticeably affects insulin release and raises your statistical risk. This is a tendency, not a diagnosis: staying active, eating well and keeping a healthy weight go a long way, and regular blood-sugar checks are worth discussing with a doctor.

Evidence & sources

Across global populations, about 8% of people carry two copies of this variant, and about 53% carry none.

This variant appears in 54 published genetic studies: PubMed 17293876 · PubMed 17460697 · PubMed 17463246 · PubMed 17463248 · PubMed 17668382 · PubMed 18372903 · PubMed 19056611 · PubMed 19401414 · PubMed 19734900 · PubMed 20581827 · PubMed 20694148 · PubMed 20849430 · PubMed 22101970 · PubMed 22581228 · PubMed 22693455 · PubMed 22885922 · PubMed 23209189 · PubMed 23300278 · PubMed 23945395 · PubMed 24390345 · PubMed 24509480 · PubMed 25102180 · PubMed 26961502 · PubMed 27897004 · PubMed 28254843 · PubMed 28869590 · PubMed 30054458 · PubMed 30297969 · PubMed 30470734 · PubMed 30595370 · PubMed 31049640 · PubMed 31118516 · PubMed 31217584 · PubMed 32541925 · PubMed 33479058 · PubMed 33619380 · PubMed 34059833 · PubMed 34737425 · PubMed 34951656 · PubMed 35393509 · PubMed 35551307 · PubMed 35587468 · PubMed 35810165 · PubMed 37308106 · PubMed 37679419 · PubMed 38374256 · PubMed 38448586 · PubMed 38627641 · PubMed 39024449 · PubMed 39379762 · PubMed 39789286 · PubMed 40754711 · PubMed 41044249 · PubMed 41298473.

Common questions

How much does TCF7L2 raise my diabetes risk? Meta-analysis puts it at about 1.46 times the odds per copy of the risk allele. It is the strongest common variant for type 2 diabetes and still a modest effect compared with weight, age and activity.

I have two risk copies. Can I still avoid diabetes? The Diabetes Prevention Program cut progression from prediabetes to diabetes by 58% with lifestyle change, in participants not selected by genetics. Genetic risk and modifiable risk act largely independently, so a high-risk genotype is a reason to monitor blood sugar rather than a fixed outcome.

Related

APOE type (Alzheimer's & cholesterol) · Asthma · Atrial fibrillation risk (4q25) · Colorectal cancer risk (8q24) · Coronary artery disease · Inflammatory bowel disease · Prostate cancer (male)